FDA warns against using sterile drugs from Ranier’s Compounding Laboratory

The FDA is warning health care professionals not to use sterile drug products from Ranier’s Compounding Laboratory due to lack of sterility assurance.
Medical supplies should immediately be checked, and any purportedly sterile drug products from the Jeannette, Pennsylvania, laboratory and pharmacy should be quarantined and not administered to patients, according to an FDA release.
A warning letter was sent to the facility in March 2017 after an inspection found “serious deficiencies” in sterile drug production practices, which could put patients at risk. In June, the FDA

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button